New drug combo aims to stop dangerous transplant complication in kids
Disease control
Not yet recruiting
This study is testing whether adding the drug vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults receiving bone marrow transplants for non-cancerous blood disorders. Researchers will enroll 55 patients aged 1-26 yea…
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC